Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386329 · ClinicalTrials.gov registry record · NA
Therapist-Guided Smartphone-Delivered CBT for MDD
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT05386329: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05386329 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05386329, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
We are testing a smartphone app that provides therapy for depression. Participants will also receive short weekly virtual appointments with a therapist. Researchers want to know if this new treatment is usable, whether participants are satisfied with it, and whether it can help lower symptoms.
Interventions
- BEHAVIORAL Mindset: Therapist-guided smartphone-delivered CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2023-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05386329
The ClinicalTrials.gov registry entry for NCT05386329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindset: Therapist-guided smartphone-delivered CBT is the first listed.
NCT05386329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05386329 about?
NCT05386329 is a clinical study titled "Therapist-Guided Smartphone-Delivered CBT for MDD". We are testing a smartphone app that provides therapy for depression. Participants will also receive short weekly virtual appointments with a therapist. Researchers want to know if this new treatment is usable, whether participants are satisfied with it, and whether it can help lower symptoms.
What is the current status of trial NCT05386329?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-05-11. Estimated completion is 2023-08-07.
What interventions are being tested in trial NCT05386329?
The interventions under investigation include: Mindset: Therapist-guided smartphone-delivered CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT05386329?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.